Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 07, 2014

HELSINN HEALTHCARE S.A. et al v. DR. REDDY'S LABORATORIES, LTD. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 13, 2015

    CORRECTED: Helsinn, Dr. Reddy's Settle Patent Suit Over Generic Aloxi

    Dr. Reddy’s Laboratories Ltd. will be allowed to sell a generic of Helsinn Healthcare SA’s anti-nausea drug Aloxi starting in 2018, according to a settlement announced Tuesday ending more than four years of patent litigation. Correction: An earlier version of this story referred to the wrong patent suit involving Helsinn, Dr. Reddy’s and Aloxi.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login